tiprankstipranks
Viking Therapeutics initiated with an Overweight at Morgan Stanley
PremiumThe FlyViking Therapeutics initiated with an Overweight at Morgan Stanley
24d ago
Viking Therapeutics presents data on amylin and calcitonin receptors
PremiumThe Fly
Viking Therapeutics presents data on amylin and calcitonin receptors
27d ago
Viking Therapeutics management to meet with Oppenheimer
PremiumThe Fly
Viking Therapeutics management to meet with Oppenheimer
1M ago
Viking seen 'holding up' against obesity competition as Roche presents data
PremiumThe FlyViking seen 'holding up' against obesity competition as Roche presents data
2M ago
Viking upgraded to Strong Buy at Raymond James after ‘opaque’ competitor update
PremiumThe Fly
Viking upgraded to Strong Buy at Raymond James after ‘opaque’ competitor update
2M ago
Roche data falls short of Viking weight loss drug, says Truist
PremiumThe Fly
Roche data falls short of Viking weight loss drug, says Truist
2M ago
Viking Therapeutics management to meet virtually with Truist
PremiumThe FlyViking Therapeutics management to meet virtually with Truist
3M ago
Viking Therapeutics reports Q1 EPS (26c), consensus (28c)
PremiumThe Fly
Viking Therapeutics reports Q1 EPS (26c), consensus (28c)
3M ago
Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100